Aortic and Mitral Valve Endocarditis-Simply Left-Sided Endocarditis or Different Entities Requiring Individual

Carolyn Weber1, Mateo Marin-Cuartas2, Sems-Malte Tugtekin3

  • 1Department of Cardiothoracic Surgery, University of Cologne, 50937 Cologne, Germany.

PubMed

Insights

Aortic valve infective endocarditis (AV-IE) and mitral valve infective endocarditis (MV-IE) differ significantly. MV-IE patients experienced more embolic events and higher long-term mortality, suggesting valve-specific treatment guidelines are needed.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiac Surgery

Background:

  • Left-sided infective endocarditis (IE) often groups aortic valve IE (AV-IE) and mitral valve IE (MV-IE).
  • Significant anatomical, physiological, and pathological differences exist between the aortic and mitral valves.
  • These differences may influence patient characteristics, pathogen profiles, and clinical outcomes in IE.

Purpose of the Study:

  • To compare patient demographics, causative pathogens, and surgical outcomes between AV-IE and MV-IE.
  • To identify predictors of mortality in patients with isolated AV-IE or MV-IE.
  • To evaluate the impact of valve specificity on long-term survival in left-sided IE.

Main Methods:

  • Retrospective analysis of 3899 patients with isolated AV-IE or MV-IE from six German cardiac surgery centers (1994-2018).
  • Univariable and multivariable analyses to assess risk factors for 30-day and 1-year mortality.
  • Log-rank test for differences in long-term mortality.

Main Results:

  • Mitral valve IE (MV-IE) patients were more frequently female and had higher rates of vegetation, cerebral embolic events, and stroke.
  • Staphylococci were more prevalent in MV-IE. MV-IE had similar 30-day mortality but significantly higher 1-year mortality compared to AV-IE.
  • Kaplan-Meier analysis revealed significantly lower long-term survival for MV-IE patients.

Conclusions:

  • Aortic valve infective endocarditis (AV-IE) and mitral valve infective endocarditis (MV-IE) exhibit distinct clinical profiles and outcomes.
  • Higher rates of embolic events and worse long-term survival in MV-IE underscore its unique challenges.
  • Valve-specific guideline recommendations for left-sided IE are warranted to optimize patient management and outcomes.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
2
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
3
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Endocarditis II: Clinical features and Diagnostic Tests01:25

Endocarditis II: Clinical features and Diagnostic Tests

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2